← Back to Clinical Trials
Recruiting NCT06820398

NCT06820398 Effects of Functional Exercise Program With Strength Load and Resistance in Children and Adolescents With Cerebral Palsy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06820398
Status Recruiting
Phase
Sponsor University of Valencia
Condition Cerebral Palsy
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2025-01-31
Primary Completion 2027-12-31

Eligibility & Interventions

Sex All sexes
Min Age 10 Years
Max Age 18 Years
Study Type INTERVENTIONAL
Interventions
Functional exercise with progressive strength and resistance loadFunctional exercises without any load

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2025-01-31 with a primary completion date of 2027-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This research project aims to evaluate the benefits of a functional exercise program with strength and resistance load in adolescents with cerebral palsy (CP), specifically classifiedat levels III and IV of the Gross Motor Function Classification System (GMFCS) scale. Participants will be included into control or intervention group in this randomized controlled trial. Changes in functional percentile, quality of life, and participation in daily environments will be analyzed based on scores obtained with validated assesment scales. The study will be conducted at the Children's Neurorehabilitation Unit of Hospitalarias Foundation in Valencia, with an 18-week intervention plus a 6-month follow-up. This project seeks to provide evidence on rehabilitation strategies that promote autonomy and social inclusion for this population.

Eligibility Criteria

Inclusion Criteria: * Adolescents aged 10 to 18 years. * Diagnosis of spastic cerebral palsy (CP). * Classification at levels III or IV of the GMFCS scale. Exclusion Criteria: * Multilevel surgery with osteotomy within the last 12 months. * Microtenotomies or percutaneous needle lengthening (APAI) within the last 9months. * Botulinum toxin injections within the last 3 months. * Participation in specific strength training protocols. * Lack of cognitive ability to perform the intervention protocol activities.

Contact & Investigator

Central Contact

M.Luz Sánchez-Sánchez, PhD

✉ m.luz.sanchez@uv.es

📞 963983853

Principal Investigator

M.Luz Sánchez-Sánchez, PhD

STUDY DIRECTOR

University of Valencia

Frequently Asked Questions

Who can join the NCT06820398 clinical trial?

This trial is open to participants of all sexes, aged 10 Years or older, up to 18 Years, studying Cerebral Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06820398 currently recruiting?

Yes, NCT06820398 is actively recruiting participants. Contact the research team at m.luz.sanchez@uv.es for enrollment information.

Where is the NCT06820398 trial being conducted?

This trial is being conducted at Valencia, Spain.

Who is sponsoring the NCT06820398 clinical trial?

NCT06820398 is sponsored by University of Valencia. The principal investigator is M.Luz Sánchez-Sánchez, PhD at University of Valencia. The trial plans to enroll 40 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology